Immunovant Reports Financial Results for the Quarter Ended September 30, 2021GlobeNewsWire • 11/05/21
Immunovant, Inc. (IMVT) Up 9.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/08/21
Immunovant, Inc. (IMVT) CEO Pete Salzmann on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/21
SPAC engineering reaches new heights as scrapped deal sends pharma firm's stock plunging 36%Business Insider • 08/03/21
Immunovant Stock Plunges On $200M Equity Investment From Roivant To Support IMVT-1401 DevelopmentBenzinga • 08/02/21
Immunovant, Inc. (IMVT) Up 6.6% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 07/01/21
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021GlobeNewsWire • 06/01/21
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 04/20/21
APRIL 20, 2021, IMVT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.PRNewsWire • 04/19/21
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 04/19/21
IMVT Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021Newsfile Corp • 04/18/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 20, 2021 - IMVTNewsfile Corp • 04/16/21
SHAREHOLDER ALERT: Holzer & Holzer Encourages Immunovant Investors With Significant Losses to Contact the FirmNewsfile Corp • 04/16/21